A recent study by Genazzani et al. investigated the effect of the administration of MYO and ALA, alone or in combination, on insulin sensitivity in obese PCOS patients, evaluating the insulin maximal response to an oral glucose tolerance test before and after 12 weeks of integrative treatments. Here, INS is linked to polycystic ovary syndrome.